Cerapedics Print Logo

Clinical Dental Data (Papers)

  1. Comparison of bone grafting materials in human extraction sockets:  clinical, histologic, and histomorphometric evaluations.  Thompson DM, Rohrer MD, Prasad HS.  Implant Dentistry 2006; Vol 15:1.
  2. Sinus grafting using recombinant human tissue factor, platelet rich plasma gel, autologous bone, and anorganic bovine mineral xenograft: histologic analysis and case reports.  Philippart P, Daubie V, Pochet R.  Int J Oral Maxillofac Implants, 2005. Mar-Apr; 20(2): 274-81.
  3. 8-year onlay bone graft and ridge augmentation with PepGen P-15: a clinical and radiographic case study.  Hahn J.  Implant Dentistry 2004; Vol 13:3:228-231.
  4. Maxillary sinus augmentation with a synthetic cell-binding peptide: histological and histomorphometrical results in humans.  Degidi M, Piattelli M, Scarano A, Iezzi G, Piattelli A.  J Oral Implantol, 2004; 30(6): 376-83.
  5. Receptor technology-cell-binding to P-15: a new method of regenerating bone quickly and safely- preliminary histomorphometrical and mechanical results in sinus floor augmentations.  Valentin AH, Weber J.  Keio J Med, 2004  Sep; 53(3): 166-71.
  6. Comparative clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) and open flap debridement (DEBR) in human periodontal osseous defects: a 6-month pilot study.  Radhakrishnan S, Anusuya CN.  J Int Acad Periodontol, 2004, Jul; 6(3):101-7.
  7. Clinical, radiographic, histologic, and histomorphometric comparison of PepGen P-15 particulate and PepGen P-15 Flow in extraction sockets:  A same-mouth case study. Hahn J, Rohrer MD, Tofe AJ.  Implant Dentistry 2003; Vol 12:2:170-173.
  8. Thirty-six month followup of 25 patients treated with combination anorganic bovine- derived hydroxylapatite matrix (ABM)/cell-binding peptide (P-15) bone replacement grafts in human infrabony defects. I. Clinical findings.  Yukna RA, Krauser JT, Callan DP, et al.  Journal of Periodontology 2002; 73:123-128.
  9. Periodontal regeneration following use of ABM/P-15: A case report.  Yukna RA, Salinas TJ, Carr RF.  International Journal of Periodontics & Restorative Dentistry 2002; 22:2, 147-155.
  10. Comparison of anorganic bovine mineral with and without synthetic peptide in a sinus elevation: a case study.  Smiler, DG. Implant Dentistry 2001; Vol. 10:2:139-141.
  11. Multi-center clinical comparison of combination anorganic bovine bone-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) and ABM in human periodontal osseous defects: 6-month results.  Yukna RA, Callan DP, Krauser JT, et al.  Journal of Periodontology 2000; 71:1671-79.
  12. Human histologic and histomorphometric analysis comparing OsteoGraf/N with PepGen P-15 in maxillary sinus elevation procedure:  A case report.  Krauser JT, Rohrer MD, Wallace SS.  Implant Dentistry 2000; 9:298-302. 
  13. Advances in endosseous implants:  The ‘sandwich’ split cortical graft for dental implant placement.  Smiler DG.   Dental Implantology Update 2000; 11; 49-52. 
  14. Multi-center clinical evaluation of combination anorganic bovine bone-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) and ABM in human periodontal osseous defects: 6-month results.  Yukna RA, Callan DP, Krauser JT, et al.  Journal of Periodontology 1998; 69:655-663.